SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950129-07-003865
Filing Date
2007-08-08
Accepted
2007-08-08 16:33:44
Documents
8
Period of Report
2007-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q - QUARTERLY REPORT h48953e10vq.htm 10-Q 244642
2 NOVATED AND RESTATED TECHNOLOGY LICENSE AGREEMENT h48953exv10w1.htm EX-10.1 220143
3 AMENDED AND RESTATED RESEARCH AND DEVELOPMENT AGREEMENT h48953exv10w2.htm EX-10.2 278578
4 PURCHASE OPTION AGREEMENT h48953exv10w3.htm EX-10.3 272289
5 RESEARCH COST SHARING, PAYMENT AND EXTENSION AGREEMENT h48953exv10w4.htm EX-10.4 33799
6 CERTIFICATION OF CEO PURSUANT TO SECTION 302 h48953exv31w1.htm EX-31.1 8665
7 CERTIFICATION OF CFO PURSUANT TO SECTION 302 h48953exv31w2.htm EX-31.2 8908
8 CERTIFICATION PURSUANT TO SECTION 906 h48953exv32w1.htm EX-32.1 4079
  Complete submission text file 0000950129-07-003865.txt   1072623
Mailing Address 8800 TECHNOLOGY FOREST PLACE THE WOODLANDS TX 77381
Business Address 8800 TECHNOLOGY FOREST PLACE THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC./DE (Filer) CIK: 0001062822 (see all company filings)

IRS No.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30111 | Film No.: 071036080
SIC: 2834 Pharmaceutical Preparations